Citius Pharmaceuticals Inc (CTXR) has risen 6.50% Thursday In Premarket Trading

Thursday, January 26, 2023 06:56 AM | InvestorsObserver Analysts

Mentioned in this article

Citius Pharmaceuticals Inc (CTXR) is up Thursday morning, with the stock rising 6.50% in pre-market trading to 1.31. CTXR's short-term technical score of 81 indicates that the stock has traded more bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 111 out of 146 industries, CTXR ranks higher than 83% of stocks. Citius Pharmaceuticals Inc has risen 46.43% over the past month, closing at $0.85 on December 29. During this period of time, the stock fell as low as $0.78 and as high as $1.48. CTXR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.

CTXR has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CTXR!
Citius Pharmaceuticals Inc has a Long-Term Technical rank of 38. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 62% of the market scoring higher. In the Biotechnology industry which is number 125 by this metric, CTXR ranks better than 125% of stocks.

Important Dates for Investors in CTXR:

-Citius Pharmaceuticals Inc is set to release earnings on 2/9/2023. Over the last 12 months, the company has reported EPS of $-0.22. -We do not have a set dividend date for Citius Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Citius Pharmaceuticals Inc (CTXR)

Share this article: